Glial reactions in Parkinson's disease

McGeer, Patrick L., McGeer, Edith G.·2008·Movement Disorders

Cited by (700)

Items 301–400 of 700

  1. Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons
    A. Machado, Antonio J. Herrera, Jose Luis Venero, Marti Santiago, Rocío M. de Pablos, Ruth F. Villarán, Ana M. Espinosa‐Oliva, Sandro Argüelles, M. Sarmiento, María José Delgado‐Cortés et al. · 2011 · ISRN Neurology
  2. Inflammation and clinical presentation in neurodegenerative disease: a volatile relationship
    Brianne Magouirk Bettcher, Joel H. Kramer · 2012 · Neurocase
  3. HLA rs3129882 variant in Chinese Han patients with late-onset sporadic Parkinson disease
    Yi Guo, Xiong Deng, Wen Zheng, Hongbo Xu, Zhi Jian Song, Hui Wen Liang, Lei Jin, Xuhong Jiang, Ziqiang Luo, Hao Deng · 2011 · Neuroscience Letters
  4. Tissue Response to Deep Brain Stimulation and Microlesion: A Comparative Study
    Vinata Vedam‐Mai, Massoud Baradaran-Shoraka, Brent A. Reynolds, Michael S. Okun · 2016 · Neuromodulation Technology at the Neural Interface
  5. Resolvin D1 Attenuates Mpp+-Induced Parkinson Disease via Inhibiting Inflammation in PC12 Cells
    Jinyan Xu, Xiang Gao, Chunying Yang, Li Chen, Zhengjun Chen · 2017 · Medical Science Monitor
  6. Anti-inflammatory properties of Honokiol in activated primary microglia and astrocytes
    Uta Rickert, François Cossais, Marvin Heimke, Philipp Arnold, Andrea Preuße-Prange, Henrik Wilms, Ralph Lucius · 2018 · Journal of Neuroimmunology
  7. Apocyanin, a Microglial NADPH Oxidase Inhibitor Prevents Dopaminergic Neuronal Degeneration in Lipopolysaccharide-Induced Parkinson’s Disease Model
    Neha Sharma, Bimla Nehru · 2015 · Molecular Neurobiology
  8. Role of astrocytes in major neurological disorders: The evidence and implications
    Caterina Scuderi, Claudia Stecca, Aniello Iacomino, Luca Steardo · 2013 · IUBMB Life
  9. Age-dependent and cell-population-restricted LRRK2 expression in normal mouse spleen
    Tatsunori Maekawa, Makoto Kubo, Ikue Yokoyama, Etsuro Ohta, Fumiya Obata · 2010 · Biochemical and Biophysical Research Communications
  10. Influence of energy deficiency on the subcellular processes of Substantia Nigra Pars Compacta cell for understanding Parkinsonian neurodegeneration
    Vignayanandam Ravindernath Muddapu, V. Srinivasa Chakravarthy · 2021 · Scientific Reports
  11. Sex‐ and brain region‐specific role of cytochrome c oxidase in 1‐methyl‐4‐phenylpyridinium‐mediated astrocyte vulnerability
    Syama Sundar Boyalla, Marion Barbara Victor, André Roemgens, Cordian Beyer, Susanne Arnold · 2011 · Journal of Neuroscience Research
  12. Unraveling the Role of Astrocytes in Subthalamic Nucleus Deep Brain Stimulation in a Parkinson’s Disease Rat Model
    Ana Carolina Pinheiro Campos, Daniel Seicho Kikuchi, Amanda F. N. Paschoa, Mayra Akemi Kuroki, Erich Talamoni Fonoff, Clement Hamani, Rosana L. Pagano, Marina S. Hernandes · 2020 · Cellular and Molecular Neurobiology
  13. KDS2010, a Newly Developed Reversible MAO-B Inhibitor, as an Effective Therapeutic Candidate for Parkinson's Disease
    Min‐Ho Nam, Jong‐Hyun Park, Hyo Jung Song, Jin‐Sung Choi, Siwon Kim, Bo Ko Jang, Hyung Ho Yoon, Jun Young Heo, Hyowon Lee, Heeyoung An et al. · 2021 · Neurotherapeutics
  14. Lipoic acid protects dopaminergic neurons in LPS-induced Parkinson’s disease model
    Yanhua Li, Qing Wen He, Jie‐Zhong Yu, Chunyun Liu, Ling Feng, Zhi Chai, Qing Wang, Hongzhen Zhang, Guang‐Xian Zhang, Bao‐Guo Xiao et al. · 2015 · Metabolic Brain Disease
  15. Neuroprotection of microglial conditioned medium on 6‐hydroxydopamine‐induced neuronal death: role of transforming growth factor beta‐2
    Elisabetta Polazzi, Emiliano Peña‐Altamira, Simona Eleuteri, Maria Raffaella Barbaro, Chiara Casadio, Antonio Contestabile, Barbara Monti · 2009 · Journal of Neurochemistry
  16. Infiltration of circulating myeloid cells through CD95L contributes to neurodegeneration in mice
    Gao, Liang, Brenner, David, Llorens-Bobadilla, Enric, Saiz-Castro, Gonzalo, Frank, Tobias, Wieghofer, Peter, Hill, Oliver, Thiemann, Meinolf, Karray, Saoussen, Prinz, Marco et al. · 2015 · Journal of Experimental Medicine
  17. Oral Treatment with the NADPH Oxidase Antagonist Apocynin Mitigates Clinical and Pathological Features of Parkinsonism in the MPTP marmoset Model
    Ingrid H.C.H.M. Philippens, Jacqueline A. M. Wubben, Bente R. Finsen, Bert A. ‘t Hart · 2013 · Journal of Neuroimmune Pharmacology
  18. The mechanism of action of MPTP-induced neuroinflammation and its modulation by melatonin in rat astrocytoma cells, C6
    Rituraj Niranjan, Chandishwar Nath, Rakesh Shukla · 2010 · Free Radical Research
  19. Expression of Tgfβ1 and Inflammatory Markers in the 6-hydroxydopamine Mouse Model of Parkinson’s Disease
    Stefan Jean-Pierre Haas, Xiaolai Zhou, Venissa Machado, Andreas Wree, Kerstin G. KRIEGLSTEIN, Björn Spittau · 2016 · Frontiers in Molecular Neuroscience
  20. Screening of Toll-Like Receptors Expression in Multiple System Atrophy Brains
    Brudek, Tomasz, Winge, Kristian, Agander, Tina Klitmøller, Pakkenberg, Bente · 2013 · Neurochemical Research
  21. Methanol extract of Evodia lepta displays Syk/Src-targeted anti-inflammatory activity
    Ju Young Yoon, Hye Yoon Jeong, Shi Hyoung Kim, Han Gyung Kim, Gyeongsug Nam, Jin Pyo Kim, Deok Hyo Yoon, Hyunsik Hwang, Tae Woong Kimc, Sungyoul Hong et al. · 2013 · Journal of Ethnopharmacology
  22. Diapocynin prevents early Parkinson's disease symptoms in the leucine-rich repeat kinase 2 (LRRK2R1441G) transgenic mouse
    Brian P. Dranka, Alison Gifford, Anamitra Ghosh, Jacek Zielonka, Joy Joseph, Anumantha G. Kanthasamy, Balaraman Kalyanaraman · 2013 · Neuroscience Letters
  23. Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease
    Maria Angela Samis Zella, Judith Metzdorf, Friederike Ostendorf, Fabian Maass, Siegfried Muhlack, Ralf Gold, Aiden Haghikia, Lars Tönges · 2019 · Cells
  24. A Computational Model of Loss of Dopaminergic Cells in Parkinson's Disease Due to Glutamate-Induced Excitotoxicity
    Vignayanandam Ravindernath Muddapu, Alekhya Mandali, Srinivasa Vaddadi Chakravarthy, Srikanth Ramaswamy · 2019 · Frontiers in Neural Circuits
  25. α-Synuclein: A therapeutic target for Parkinson’s disease?
    Kathleen A. Maguire‐Zeiss · 2008 · Pharmacological Research
  26. The α-synuclein burden hypothesis of Parkinson disease and its relationship to Alzheimer disease
    McGeer, Patrick L., McGeer, Edith G. · 2008 · Experimental Neurology
  27. The MPTP marmoset model of Parkinsonism: a multi-purpose non-human primate model for neurodegenerative diseases
    Ingrid H.C.H.M. Philippens, Bert A. ‘t Hart, German Torres · 2010 · Drug Discovery Today
  28. Inhibition of store-operated calcium entry in microglia by helminth factors: implications for immune suppression in neurocysticercosis
    Yuyang Sun, Arun Chauhan, Pramod Sukumaran, Jyotika Sharma, Brij Bhan Singh, Bibhuti Bhusan Mishra · 2014 · Journal of Neuroinflammation
  29. Liver X receptors activation, through TO901317 binding, reduces neuroinflammation in Parkinson’s disease
    Irene Paterniti, Michela Campolo, Rosalba Siracusa, Marika Cordaro, Rosanna Di Paola, Vittorio Calabrese, Michele Navarra, Salvatore Cuzzocrea, Emanuela Esposito · 2017 · PLoS ONE
  30. Glial activation precedes alpha-synuclein pathology in a mouse model of Parkinson’s disease
    María Izco, Javier Blesa, Guglielmo Verona, J Allen D Cooper, Lydia Alvarez‐Erviti · 2020 · Neuroscience Research
  31. LPS-induced iNOS expression in N9 microglial cells is suppressed by geniposide via ERK, p38 and nuclear factor-κB signaling pathways
    Gu Zhang, Junlin He, Xiaoyan Xie, Chao Yu · 2012 · International Journal of Molecular Medicine
  32. Brain Arachidonic Acid Cascade Enzymes are Upregulated in a Rat Model of Unilateral Parkinson Disease
    Ho‐Joo Lee, Richard Paul Bazinet, Stanley Isaac Rapoport, Abesh Kumar Bhattacharjee · 2009 · Neurochemical Research
  33. Complex Changes in the Innate and Adaptive Immunity Accompany Progressive Degeneration of the Nigrostriatal Pathway Induced by Intrastriatal Injection of 6-Hydroxydopamine in the Rat
    Giulia Ambrosi, Nataša Z. Kuštrimović, Francesca Siani, Emanuela Rasini, Silvia Cerri, Cristina Ghezzi, Giuseppe Dicorato, Sofia Caputo, Franca Marino, Marco Cosentino et al. · 2017 · Neurotoxicity Research
  34. The Nurr1 Ligand,1,1-bis(3′-Indolyl)-1-(p-Chlorophenyl)Methane, Modulates Glial Reactivity and Is Neuroprotective in MPTP-Induced Parkinsonism
    Sean L. Hammond, Katriana A. Popichak, Xi Li, Lindsay G. Hunt, Evan H. Richman, Pranav U. Damale, Edwin K. P. Chong, Donald S. Backos, Stephen H Safe, Ronald B. Tjalkens · 2018 · Journal of Pharmacology and Experimental Therapeutics
  35. Antiinflammatory Effects of Orientin-2″-O-Galactopyranoside on Lipopolysaccharide-Stimulated Microglia
    Xiang Zhou, Ping Gan, Lili Hao, Tao Li, Jia Jia, Bo Gao, Jiangyun Liu, Long Tai Zheng, Xuechu Zhen · 2014 · Biological and Pharmaceutical Bulletin
  36. Dopaminergic Neurodegeneration in the Mouse Is Associated with Decrease of Viscoelasticity of Substantia Nigra Tissue
    Elisabeth G. Hain, Charlotte Klein, Tonia Munder, Jürgen Braun, Kerstin Riek, Susanne G. Mueller, Ingolf Sack, Barbara Steiner · 2016 · PLoS ONE
  37. N-methyltetrahydropyridines and pyridinium cations as toxins and comparison with naturally-occurring alkaloids
    Tomás Herraiz · 2016 · Food and Chemical Toxicology
  38. Autophagy Stimulation Decreases Dopaminergic Neuronal Death Mediated by Oxidative Stress
    Marcela J. Ramirez-Moreno, Ana Patricia Duarte-Jurado, Yareth Gopar‐Cuevas, Alfredo González-Alcocer, María de Jesús Loera‐Arias, Odila Saucedo Cárdenas, Roberto Montes‐de‐Oca‐Luna, Humberto Rodríguez‐Rocha, Aracely García‐García · 2019 · Molecular Neurobiology
  39. Neuroplasticity and Neuroprotective Effect of Treadmill Training in the Chronic Mouse Model of Parkinson’s Disease
    Palasz, Ewelina, Niewiadomski, Wiktor, Gasiorowska, Anna, Mietelska-Porowska, Anna, Niewiadomska, Grazyna · 2019 · Neural Plasticity
  40. Syk and Src are major pharmacological targets of a Cerbera manghas methanol extract with kaempferol-based anti-inflammatory activity
    Hye Yoon Jeong, Gi‐Ho Sung, Ji Hye Kim, Ju Young Yoon, Yanyan Yang, Jae Gwang Park, Shi Hyoung Kim, Young‐Su Yi, Woo Seok Yang, Deok Hyo Yoon et al. · 2013 · Journal of Ethnopharmacology
  41. Switching the Microglial Harmful Phenotype Promotes Lifelong Restoration of Subtantia Nigra Dopaminergic Neurons from Inflammatory Neurodegeneration in Aged Mice
    Francesca L’Episcopo, Cataldo Tirolo, Nunzio Testa, Salvatore Caniglia, Maria C. Morale, Francesco Impagnatiello, Bianca Marchetti · 2011 · Rejuvenation Research
  42. Proton pump inhibitors reduce interferon‐γ‐induced neurotoxicity and STAT3 phosphorylation of human astrocytes
    Sadayuki Hashioka, Andis Klegeris, Patrick L. McGeer · 2011 · Glia
  43. Genetic LRRK2 models of Parkinson's disease: Dissecting the pathogenic pathway and exploring clinical applications
    Zhenyu Yue, Martin Lenard Lachenmayer · 2011 · Movement Disorders
  44. Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease
    J. Korecka, E. Moloney, R. Eggers, B. Hobo, Sanny Scheffer, N. Ras-Verloop, R. Pasterkamp, D. Swaab, A. Smit, R. V. van Kesteren et al. · 2017 · Journal of Neuroscience
  45. Inflammation and Parkinson's disease pathogenesis: Mechanisms and therapeutic insight
    Gianluigi Forloni, Pietro La Vitola, Milica Cerovic, Claudia Balducci · 2020 · Progress in molecular biology and translational science
  46. Diverse midbrain dopaminergic neuron subtypes and implications for complex clinical symptoms of Parkinson’s disease
    Kathleen Carmichael, Breanna T Sullivan, Elena Lopez, Lixin Sun, Huaibin Cai · 2021 · Ageing and Neurodegenerative Diseases
  47. Chronic mild stress augments MPTP induced neurotoxicity in a murine model of Parkinson's disease
    Janakiraman, Udaiyappan, Manivasagam, Thamilarasan, Justin Thenmozhi, Arokiasamy, Dhanalakshmi, Chinnasamy, Essa, Musthafa Mohamed, Song, Byoung-Joon, Guillemin, Gilles J · 2017 · Physiology & Behavior
  48. Glia-derived extracellular vesicles in parkinson’s disease.
    Marchetti, Bianca, Leggio, Loredana, L’Episcopo, Francesca, Vivarelli, Silvia, Tirolo, Cataldo, Paternò, Greta, Giachino, Carmela, Caniglia, Salvatore, Serapide, Maria Francesca, Iraci, Nunzio · 2020 · Journal of Clinical Medicine
  49. Neuroprotective effect of arctigenin against neuroinflammation and oxidative stress induced by rotenone
    Na Zhang, Deqiang Dou, Xiaoku Ran, Ting‐Guo Kang · 2018 · RSC Advances
  50. Omega‐3 fatty acid eicospentaenoic acid attenuates MPP +‐induced neurodegeneration in fully differentiated human SH ‐ SY 5Y and primary mesencephalic cells
    Dirk W. Luchtman, Qingjia Meng, Xiaofeng Wang, Di Shao, Cai Song · 2012 · Journal of Neurochemistry
  51. Viral-toxin interactions and Parkinson’s disease: poly(I:C) priming enhanced the neurodegenerative effects of paraquat
    Jessica Bobyn, Emily N. Mangano, Anusha Gandhi, Eric Nelson, Kerry Moloney, Melanie Clarke, Shawn P. Hayley · 2012 · Journal of Neuroinflammation
  52. Minimally Toxic Dose of Lipopolysaccharide and α-Synuclein Oligomer Elicit Synergistic Dopaminergic Neurodegeneration: Role and Mechanism of Microglial NOX2 Activation
    Zhang, Wei, Gao, Jun-hua, Yan, Zhao-fen, Huang, Xi-yan, Guo, Peng, Sun, Li, Liu, Zhuo, Hu, Yang, Zuo, Li-jun, Yu, Shu-yang et al. · 2018 · Molecular Neurobiology
  53. Adenovirus-induced Reactive Astrogliosis Exacerbates the Pathology of Parkinson’s Disease
    Heeyoung An, Hyowon Lee, Seulkee Yang, Woojin Won, Changjoon Justin Lee, Min‐Ho Nam · 2021 · Experimental Neurobiology
  54. Maternal Omega-3 Supplement Improves Dopaminergic System in Pre- and Postnatal Inflammation-Induced Neurotoxicity in Parkinson’s Disease Model
    Ana Márcia Delattre, Bruno Carabelli, Marco Mori, Paula G. Kempe, Luiz Eduardo Rizzo de Souza, Sílvio Marques Zanata, Ricardo Borges Machado, Deborah Suchecki, Belmira L. S. Andrade da Costa, Marcelo M. S. Lima et al. · 2016 · Molecular Neurobiology
  55. Neuroprotective effect of agmatine (decarboxylated l -arginine) against oxidative stress and neuroinflammation in rotenone model of Parkinson’s disease
    Elsayed K. El-Sayed, AAE Ahmed, Engy M. El Morsy, Shahira Nofal · 2018 · Human & Experimental Toxicology
  56. Protective Role of Capsaicin in Neurological Disorders: An Overview
    Sakshi Tyagi, Nikhila Shekhar, Ajit Kumar Thakur · 2022 · Neurochemical Research
  57. The role of neurotransmitter systems in mediating deep brain stimulation effects in Parkinson’s disease
    Faisal Alosaimi, Jackson Tyler Boonstra, Sonny K. H. Tan, Yasin Temel, Ali Jahanshahi · 2022 · Frontiers in Neuroscience
  58. The cGAS-STING-interferon regulatory factor 7 pathway regulates neuroinflammation in Parkinson’s disease
    Shengyang Zhou, Ting Li, Wei Yan Zhang, Jian Wu, Hui Hong, Wei Quan, Xin-yu Qiao, Chun Cui, Chen-Meng Qiao, Weijiang Zhao et al. · 2024 · Neural Regeneration Research
  59. Altered Serum IgG Levels to α-Synuclein in Dementia with Lewy Bodies and Alzheimer’s Disease
    Niklas K. U. Koehler, Elke Stransky, Mona Shing, Susanne Gaertner, Mirjam Meyer, Brigitte Schreitmüller, Thomas Leyhe, Christoph Laske, Walter Maetzler, Phillipp Kahle et al. · 2013 · PLoS ONE
  60. CD200 Inhibits Inflammatory Response by Promoting KATP Channel Opening in Microglia Cells in Parkinson’s Disease
    Yi Ren, M. Ye, Sheng-Di Chen, Jian-Qing Ding · 2016 · Medical Science Monitor
  61. Indomethacin promotes survival of new neurons in the adult murine hippocampus accompanied by anti-inflammatory effects following MPTP-induced dopamine depletion
    Elisabeth G. Hain, Maria Sparenberg, Justyna Rasińska, Charlotte Klein, Levent Akyüz, Barbara Steiner · 2018 · Journal of Neuroinflammation
  62. Exploring the Use of Intracranial and Extracranial (Remote) Photobiomodulation Devices in Parkinson’s Disease: A Comparison of Direct and Indirect Systemic Stimulations
    Daniel M. Johnstone, Catherine Hamilton, Luke C. Gordon, Cécile Moro, Napoleon Torres-Martinez, F. Nicklason, Jonathan Stone, Alim‐Louis Benabid, John Mitrofanis · 2021 · Journal of Alzheimer s Disease
  63. Role of soluble CD14 in cerebrospinal fluid as a regulator of glial functions
    Guo Nan Yin, Hyejin Jeon, Shinrye Lee, Ho‐Won Lee, Je‐Yoel Cho, Kyoungho Suk · 2009 · Journal of Neuroscience Research
  64. Regulation of matrix metalloproteinase-9 and tissue plasminogen activator activity by alpha-synuclein in rat primary glial cells
    So Hyun Joo, Kyoung Ja Kwon, Ji‐Woon Kim, Joo Wan Kim, Mohammad Rakibul Hasan, He-Jin Lee, Seol‐Heui Han, Chan Young Shin · 2009 · Neuroscience Letters
  65. Impact of sex on neuroimmune contributions to Parkinson’s disease
    Mélanie Bourque, Marc Morissette, Denis Soulet, Thérèse Di Paolo · 2023 · Brain Research Bulletin
  66. Clinical features and dysfunctions of iron metabolism in Parkinson disease patients with hyper echogenicity in substantia nigra: a cross-sectional study
    Shuyang Yu, Chen-Jie Cao, Li-jun Zuo, Zejie Chen, Tenghong Lian, Fang Wang, Yang Hu, Ying‐shan Piao, Lixia Li, Peng Fei Guo et al. · 2018 · BMC Neurology
  67. Intracranial Injection of LPS in Rat as Animal Model of Neuroinflammation
    Ana M. Espinosa‐Oliva, Rocío M. de Pablos, Antonio J. Herrera · 2013 · Methods in molecular biology
  68. The degeneration of dopaminergic synapses in Parkinson's disease: A selective animal model
    Ingrid Moráles, Alberto Sánchez, Clara Rodriguez‐Sabate, Manuel Rodrı́guez · 2015 · Behavioural Brain Research
  69. Neuroprotective and anti‐inflammatory effects of the adenosine A2A receptor antagonist ST1535 in a MPTP mouse model of Parkinson's disease
    Lucia Frau, Franco Borsini, Jadwiga Wardas, Amit Khairnar, Nicoletta Schintu, Micaela Morelli · 2010 · Synapse
  70. Kinetics of Microglial Activation and Degeneration of Dopamine-Containing Neurons in a Rat Model of Parkinson Disease Induced by 6-Hydroxydopamine
    Vincent Henry, Vincent Paillé, Faustine Lelan, Philippe Brachet, Philippe Damier · 2009 · Journal of Neuropathology & Experimental Neurology
  71. GSTpi Expression in MPTP-Induced Dopaminergic Neurodegeneration of C57BL/6 Mouse Midbrain and Striatum
    Margarida Castro‐Caldas, Andreia Neves Carvalho, Isabel Peixeiro, Elsa Rodrigues, Maria Celeste Lechner, Maria João Gama · 2008 · Journal of Molecular Neuroscience
  72. Modeling early Parkinson's disease pathology with chronic low dose MPTP treatment
    J. Korecka, R. Eggers, D. Swaab, K. Bossers, J. Verhaagen · 2013 · Restorative Neurology and Neuroscience
  73. Methanol extract of Hopea odorata suppresses inflammatory responses via the direct inhibition of multiple kinases
    Yanyan Yang, Tao Yu, Yong Gyu Lee, Woo Seok Yang, Ju-Eun Oh, Deok Jeong, Sukchan Lee, Tae Woong Kim, Yung Chul Park, Gi‐Ho Sung et al. · 2012 · Journal of Ethnopharmacology
  74. Neuroprotective effects of riluzole in early phase Parkinson's disease on clinically relevant parameters in the marmoset MPTP model
    Peternella S. Verhave, Marjan J. Jongsma, Roland M. van den Berg, Raymond A.P. Vanwersch, August Benjamin Smit, Ingrid H.C.H.M. Philippens · 2011 · Neuropharmacology
  75. Boosting Antioxidant Self-defenses by Grafting Astrocytes Rejuvenates the Aged Microenvironment and Mitigates Nigrostriatal Toxicity in Parkinsonian Brain via an Nrf2-Driven Wnt/β-Catenin Prosurvival Axis
    Maria Francesca Serapide, Francesca L’Episcopo, Cataldo Tirolo, Nunzio Testa, Salvatore Caniglia, Carmela Giachino, Bianca Marchetti · 2020 · Frontiers in Aging Neuroscience
  76. Inhibition of repulsive guidance molecule-a protects dopaminergic neurons in a mouse model of Parkinson’s disease
    Wakana Oda, Y. Fujita, Kousuke Baba, H. Mochizuki, H. Niwa, T. Yamashita · 2021 · Cell Death and Disease
  77. Insights Into the Role of Platelet-Derived Growth Factors: Implications for Parkinson’s Disease Pathogenesis and Treatment
    Dan Li, Le‐Tian Huang, Cheng-pu Zhang, Qiang Li, Jiahe Wang · 2022 · Frontiers in Aging Neuroscience
  78. Combined chronic copper exposure and aging lead to neurotoxicity in vivo
    Alfredo González-Alcocer, Yareth Gopar‐Cuevas, Adolfo Soto‐Domínguez, Uziel Castillo-Velázquez, María de Jesús Loera‐Arias, Odila Saucedo Cárdenas, Roberto Montes‐de‐Oca‐Luna, Aracely García‐García, Humberto Rodríguez‐Rocha · 2023 · NeuroToxicology
  79. Upregulation of histone deacetylase 2 in laser capture nigral microglia in Parkinson's disease
    Yuyan Tan, Elaine Delvaux, Jennifer Nolz, Paul D. Coleman, Shengdi Chen, Diego Mastroeni · 2018 · Neurobiology of Aging
  80. Prostaglandin D2/J2 signaling pathway in a rat model of neuroinflammation displaying progressive parkinsonian-like pathology: potential novel therapeutic targets
    Chuhyon Corwin, Anastasia Nikolopoulou, Allen L. Pan, Mariela Nunez-Santos, Shankar Vallabhajosula, Peter A. Serrano, John W. Babich, Maria E. Figueiredo-Pereira · 2018 · Journal of Neuroinflammation
  81. Monoaminergic regulation of nociceptive circuitry in a Parkinson's disease rat model
    Ana Carolina Pinheiro Campos, Miriã Benatti Berzuino, Marina S. Hernandes, Erich Talamoni Fonoff, Rosana L. Pagano · 2019 · Experimental Neurology
  82. Marijuana Compounds: A Nonconventional Approach to Parkinson’s Disease Therapy
    Mariana Babayeva, Haregewein Assefa, Paramita Basu, Sanjeda R Chumki, Zvi G. Loewy · 2016 · Parkinson s Disease
  83. Neuroprotective effects of 2,4-dinitrophenol in an acute model of Parkinson’s disease
    Yujeong Lee, Gwangbeom Heo, Kyung Moon Lee, Ah Hyun Kim, Ki Wung Chung, Eunok Im, Hae Young Chung, Jaewon Lee · 2017 · Brain Research
  84. A worldwide study of white matter microstructural alterations in people living with Parkinson’s disease
    Conor Owens‐Walton, Talia M. Nir, Sarah Al–Bachari, Sonia Ambrogi, Tim Anderson, Ítalo Karmann Aventurato, Fernando Cendes, Yao-Liang Chen, Valentina Ciullo, Phil Cook et al. · 2024 · npj Parkinson s Disease
  85. Neuron-derived IgG protects dopaminergic neurons from insult by 6-OHDA and activates microglia through the FcγR I and TLR4 pathways
    Jie Zhang, Na Niu, Mingyu Wang, Michael A. McNutt, Donghong Zhang, Baogang Zhang, Shijun Lu, Yuqing Liu, Zhihui Liu · 2013 · The International Journal of Biochemistry & Cell Biology
  86. Protection by mTOR Inhibition on Zymosan-Induced Systemic Inflammatory Response and Oxidative/Nitrosative Stress: Contribution of mTOR/MEK1/ERK1/2/IKKβ/IκB-α/NF-κB Signalling Pathway
    Seyhan Sahan-Firat, Meryem Temiz-Resitoglu, D. Guden, S. P. Kucukkavruk, B. Tunçtan, A. N. Sari, Zumrut Kocak, K. Malik · 2017 · Inflammation
  87. Current Status of Stem Cell-Derived Therapies for Parkinson’s Disease: From Cell Assessment and Imaging Modalities to Clinical Trials
    Se Eun Jang, Lifeng Qiu, Ling Ling Chan, Eng‐King Tan, Li Zeng · 2020 · Frontiers in Neuroscience
  88. Pathomechanism Characterization and Potential Therapeutics Identification for Parkinson’s Disease Targeting Neuroinflammation
    Chiung‐Mei Chen, Chien-Yu Yen, Wan-Ling Chen, Chih‐Hsin Lin, Yih‐Ru Wu, Kuo‐Hsuan Chang, Guey‐Jen Lee‐Chen · 2021 · International Journal of Molecular Sciences
  89. Mechanism for antiParkinsonian effect of resveratrol: Involvement of transporters, synaptic proteins, dendrite arborization, biochemical alterations, ER stress and apoptosis
    Ashish Kumar Singh, Arun Kumar Yadawa, Swati Chaturvedi, Muhammad Wahajuddin, Amit Mishra, Sarika Singh · 2021 · Food and Chemical Toxicology
  90. Deletion of caspase-8 in mouse myeloid cells blocks microglia pro-inflammatory activation and confers protection in MPTP neurodegeneration model
    Edel T. Kavanagh, Miguel Ángel Burguillos, Alejandro Carrillo-Jiménez, Maria José Oliva-Martín, Martiniano Santiago, Johanna Rodhe, Bertrand Joseph, Jose Luis Venero · 2015 · Aging
  91. The histone deacetylase inhibitor suberoylanilide hydroxamic acid attenuates human astrocyte neurotoxicity induced by interferon-γ
    Sadayuki Hashioka, Andis Klegeris, Patrick L. McGeer · 2012 · Journal of Neuroinflammation
  92. Astrocytes As the Main Players in Primary Degenerative Disorders of the Human Central Nervous System
    Francisco Capani, Cecilia Quarracino, Roberto L. Caccuri, Roberto E.P. Sica · 2016 · Frontiers in Aging Neuroscience
  93. Histomorphological evaluations on the frontal cortex extrapyramidal cell layer following administration of N-Acetyl cysteine in aluminum induced neurodegeneration rat model
    Adejoke Elizabeth Memudu, Pantong Samson, Osahon Roli Itohan · 2020 · Metabolic Brain Disease
  94. Neuroprotective effects of (±)-catechin against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity in mice
    Hao-Lan Ruan, Yi Yang, Xiaonan Zhu, Xuelan Wang, Ruzhu Chen · 2008 · Neuroscience Letters
  95. New insights on Parkinson’s disease genes: the link between mitochondria impairment and neuroinflammation
    Dorit Trudler, Yuval Nash, Dan Frenkel · 2015 · Journal of Neural Transmission
  96. Self‐induced accumulation of glutamate in striatal astrocytes and basal ganglia excitotoxicity
    Ingrid Moráles, Manuel Rodrı́guez · 2012 · Glia
  97. Neuropathology of Parkinson’s Disease
    K. A. Jellinger · 2014 · Springer eBooks
  98. The immunological challenges of cell transplantation for the treatment of Parkinson's disease
    Amanda L. Piquet, Kala Venkiteswaran, Neena I. Marupudi, Matthew Berk, Thyagarajan Subramanian · 2012 · Brain Research Bulletin
  99. Modeling Cell-Cell Interactions in Parkinson’s Disease Using Human Stem Cell-Based Models
    Katrin Simmnacher, Jonas Lanfer, Tania Rizo, Johanna Kaindl, Beate Winner · 2020 · Frontiers in Cellular Neuroscience
  100. Overexpression of SIRT3 Suppresses Oxidative Stress-induced Neurotoxicity and Mitochondrial Dysfunction in Dopaminergic Neuronal Cells
    Shinrye Lee, Yu‐Mi Jeon, Myungjin Jo, Hyung‐Jun Kim · 2021 · Experimental Neurobiology